Stock Events

Novo Nordisk 

€114
231
-€1-0.87% Friday 20:49

Statistics

Day High
115.5
Day Low
114
52W High
-
52W Low
-
Volume
452
Avg. Volume
-
Mkt Cap
286.86B
P/E Ratio
40.87
Dividend Yield
1.51%
Dividend
1.72

Upcoming

Dividends

1.51%Dividend Yield
10Y Growth
16.18%
5Y Growth
24.84%
3Y Growth
36.19%
1Y Growth
80.82%

Earnings

2MayExpected
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
0
2.11
4.23
6.34
Expected EPS
0.814
Actual EPS
0

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NOVA.F. It's not an investment recommendation.

About

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson's diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Show more...
CEO
Mr. Lars Fruergaard Jorgensen
Employees
45971
Country
US
ISIN
US6701002056
WKN
000866931

Listings